EUrd
Latest Information Update: 15 Mar 2007
Price :
$50 *
At a glance
- Originator Hokkaido University; Kanazawa University; Taiho Pharmaceutical
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA-directed RNA polymerase inhibitors; Ribonucleotide reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer